CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 33 enrolled
Drug / intervention
All participants received Biotrue ONEday lenses with and without an alternate packaging solution (EPG03)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05129488
NCT05129488N/ACompleted

2 Hour Dispensing Evaluation of Biotrue ONEday Contact Lenses With EPG03 Packaging Solution Compared to Commercially Available Biotrue ONEday Contact Lenses

Bausch & Lomb Incorporated·interventional·Posted Nov 22, 2021·Updated Apr 16, 2024

In Brief

A clinical study evaluating All participants received Biotrue ONEday lenses with and without an alternate packaging solution (EPG03) for Contact Lens Wearer. Completed, enrolled 33 participants across 1 site.

Detailed Summary

The objective of this 2 hour study is to evaluate the clinical performance of Biotrue ONEday lenses with an alternate packaging solution (EPG03) compared to commercially available Biotrue ONEday lenses. This novel contact lens packaging solution contains known elements in the ophthalmic industry and is safe for use.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedNov 22, 2021
Enrollment StartSep 15, 2021
Primary CompletionSep 20, 2021
TodayJul 2, 2026
Enrollment to primary: 5 daysPosted 4.6 years ago

Interventions

All participants received Biotrue ONEday lenses with and without an alternate packaging solution (EPG03)device

Participants were given both Commercially available Biotrue ONEday lenses and Biotrue ONEday Contact Lenses with EPG03 Packaging Solution. Lens material is made from a hydrophilic copolymer of 2- hydroxyethyl methacrylate and N-vinylpyrrolidone and is 78% water by weight when immersed in saline solution.EPG03 Packaging Solution contains a phosphate buffered saline solution containing potassium chloride, poloxamine, poloxamer 181, glycerol (glycerin), erythritol, and polyquaternium-1.